Rituximab-Induced Psoriasis in a Patient with Granulomatosis with Polyangitis Treated with Adalimumab

Dermatofibrosarcoma protuberans (DFSP) with fibrosarcomatous changes in a patient with psoriasis treated with adalimumab

P soriasis is a Th1/Th17 chronic immunemediated disease, characterized by increased levels of tumor necrosis factor (TNF)-alfa. TNF-alfa blockers including adalimumab have been widely used to treat immune-mediated diseases such as inflammatory bowel disease, psoriasis, rheumatoid arthritis, and psoriatic arthritis. TNF-alfa plays a central role in the inflammation and cellular immune response a...

Refractory Wegener's granulomatosis presenting with alveolar haemorrhage, treated with rituximab.

To cite: Caetano J, Fernandes das Neves M, Oliveira S, et al. BMJ Case Rep Published online: [please include Day Month Year] doi:10.1136/bcr-2014208510 DESCRIPTION A previously healthy 57-year-old man presented with epistaxis, crusted nasal ulcers and weight loss. CT scan of the sinuses revealed an inflammatory swelling of the ethmoid and maxillary sinuses (figure 1) and CTscan of the lungs sho...

New onset of psoriasis in a patient with rheumatoid arthritis treated with rituximab.

the past hospitalization and its association with suicide attempts and ideation in patients with mdd and comparison with bmd (depressed type) group

چکیده ندارد.

Cryptosporidiosis in a patient with ankylosing spondylitis treated with adalimumab.

Cryptosporidiosis is a parasitic disease caused by a protozoan called Cryptosporidium sp. An increased number of diagnoses were made in the last 20 years, especially in patients with immunodeficiency like the acquired human immunodeficiency syndrome and induced immunodeficiency, such as in transplant patients and those who need frequent hemodialysis, has been observed. We report the case of a y...